$136,265,880
to TRUSTEES OF BOSTON UNIVERSITY
NATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES OPERATIONS
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Operations and research at the National Emerging Infectious Diseases Laboratories, a BSL-4 facility studying dangerous pathogens.
The NEIDL is critical U.S. infrastructure for pandemic preparedness and emerging pathogen research; this 2014-launched program continues essential biosafety operations.
Sustains specialized biocontainment equipment, PPE, and laboratory supply vendors serving high-security research facilities.
U.S. maintains independent BSL-4 capacity for infectious disease research; China operates competing facilities, making domestic capability strategically important.
Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-05-25. Cost: $0.003031.
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier ASST_NON_UC7AI095321_075.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.